Report Detail
Global Travelers Vaccines Market Insights, Forecast to 2025
- RnM2376054 |
- 02 April, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
The classification of Travelers Vaccines includes Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine and other vaccines. The proportion of Hepatitis Vaccine in 2016 is about 28.94%, the proportion of Japanese Encephalitis Vaccine in 2016 is about 15.67%, and the proportion of other vaccine in 2016 is about 24.55%.
Travelers Vaccines are application in Tourists, Students, Workers and others. The most of Travelers Vaccines is Tourists, and the market share of that is about 44.41 % in 2016.
North America is the largest consumption place, with a consumption market share nearly 49.42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 19.41% in 2016. And Asia Pacific in the third largest consumption region with the consumption market share of 18.09%.
The global Travelers Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Travelers Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Travelers Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Travelers Vaccines in these regions.
This research report categorizes the global Travelers Vaccines market by top players/brands, region, type and end user. This report also studies the global Travelers Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Market size by Product
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Market size by End User
Tourists
Students
Workers
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Travelers Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Travelers Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Travelers Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Travelers Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Travelers Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Travelers Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Travelers Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Travelers Vaccines Market Size Growth Rate by Product
- 1.4.2 Meningococcal Vaccine
- 1.4.3 Japanese Encephalitis Vaccine
- 1.4.4 Yellow Fever Vaccine
- 1.4.5 Hepatitis Vaccine
- 1.4.6 Cholera Vaccine
- 1.4.7 Other
- 1.5 Market by End User
- 1.5.1 Global Travelers Vaccines Market Size Growth Rate by End User
- 1.5.2 Tourists
- 1.5.3 Students
- 1.5.4 Workers
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Travelers Vaccines Market Size
- 2.1.1 Global Travelers Vaccines Revenue 2014-2025
- 2.1.2 Global Travelers Vaccines Sales 2014-2025
- 2.2 Travelers Vaccines Growth Rate by Regions
- 2.2.1 Global Travelers Vaccines Sales by Regions
- 2.2.2 Global Travelers Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Travelers Vaccines Sales by Manufacturers
- 3.1.1 Travelers Vaccines Sales by Manufacturers
- 3.1.2 Travelers Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global Travelers Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Travelers Vaccines Revenue by Manufacturers
- 3.2.1 Travelers Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Travelers Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 Travelers Vaccines Price by Manufacturers
- 3.4 Travelers Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Travelers Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Travelers Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Travelers Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Travelers Vaccines Sales by Product
- 4.2 Global Travelers Vaccines Revenue by Product
- 4.3 Travelers Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Travelers Vaccines Breakdown Data by End User
6 North America
- 6.1 North America Travelers Vaccines by Countries
- 6.1.1 North America Travelers Vaccines Sales by Countries
- 6.1.2 North America Travelers Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Travelers Vaccines by Product
- 6.3 North America Travelers Vaccines by End User
7 Europe
- 7.1 Europe Travelers Vaccines by Countries
- 7.1.1 Europe Travelers Vaccines Sales by Countries
- 7.1.2 Europe Travelers Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Travelers Vaccines by Product
- 7.3 Europe Travelers Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific Travelers Vaccines by Countries
- 8.1.1 Asia Pacific Travelers Vaccines Sales by Countries
- 8.1.2 Asia Pacific Travelers Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Travelers Vaccines by Product
- 8.3 Asia Pacific Travelers Vaccines by End User
9 Central & South America
- 9.1 Central & South America Travelers Vaccines by Countries
- 9.1.1 Central & South America Travelers Vaccines Sales by Countries
- 9.1.2 Central & South America Travelers Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Travelers Vaccines by Product
- 9.3 Central & South America Travelers Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Travelers Vaccines by Countries
- 10.1.1 Middle East and Africa Travelers Vaccines Sales by Countries
- 10.1.2 Middle East and Africa Travelers Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Travelers Vaccines by Product
- 10.3 Middle East and Africa Travelers Vaccines by End User
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline Travelers Vaccines Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 Sanofi Pasteur
- 11.2.1 Sanofi Pasteur Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sanofi Pasteur Travelers Vaccines Products Offered
- 11.2.5 Sanofi Pasteur Recent Development
- 11.3 Merck
- 11.3.1 Merck Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck Travelers Vaccines Products Offered
- 11.3.5 Merck Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Travelers Vaccines Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 CNBG
- 11.5.1 CNBG Company Details
- 11.5.2 Company Business Overview
- 11.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 CNBG Travelers Vaccines Products Offered
- 11.5.5 CNBG Recent Development
- 11.6 Sanofi Pasteur MSD
- 11.6.1 Sanofi Pasteur MSD Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sanofi Pasteur MSD Travelers Vaccines Products Offered
- 11.6.5 Sanofi Pasteur MSD Recent Development
- 11.7 Serum Institute of India
- 11.7.1 Serum Institute of India Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Serum Institute of India Travelers Vaccines Products Offered
- 11.7.5 Serum Institute of India Recent Development
- 11.8 Biokangtai
- 11.8.1 Biokangtai Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Biokangtai Travelers Vaccines Products Offered
- 11.8.5 Biokangtai Recent Development
12 Future Forecast
- 12.1 Travelers Vaccines Market Forecast by Regions
- 12.1.1 Global Travelers Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global Travelers Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 Travelers Vaccines Market Forecast by Product
- 12.2.1 Global Travelers Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global Travelers Vaccines Revenue Forecast by Product 2019-2025
- 12.3 Travelers Vaccines Market Forecast by End User
- 12.4 North America Travelers Vaccines Forecast
- 12.5 Europe Travelers Vaccines Forecast
- 12.6 Asia Pacific Travelers Vaccines Forecast
- 12.7 Central & South America Travelers Vaccines Forecast
- 12.8 Middle East and Africa Travelers Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Travelers Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Travelers Vaccines . Industry analysis & Market Report on Travelers Vaccines is a syndicated market report, published as Global Travelers Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Travelers Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
